Halozyme Therapeutics shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $1.6M | 42k | 36.96 |
| 2023-09-30 | $1.6M | 42k | 38.20 |
| 2023-06-30 | $1.6M | 44k | 36.07 |
| 2023-03-31 | $1.7M | 45k | 38.19 |
| 2022-12-31 | $2.3M | 45k | 51.42 |
| 2022-09-30 | $1.8M | 46k | 39.52 |
| 2022-06-30 | $2.1M | 47k | 43.99 |
| 2022-03-31 | $1.9M | 48k | 39.87 |
| 2021-12-31 | $1.9M | 48k | 40.20 |
| 2021-09-30 | $2.0M | 49k | 40.68 |
| 2021-06-30 | $2.1M | 47k | 45.42 |
| 2021-03-31 | $1.9M | 46k | 41.69 |
| 2020-12-31 | $2.0M | 46k | 42.72 |
| 2020-09-30 | $304k | 12k | 26.27 |
| 2020-06-30 | $322k | 12k | 26.84 |
| 2020-03-31 | $210k | 12k | 18.02 |
| 2019-12-31 | $216k | 12k | 17.70 |
| 2019-09-30 | $189k | 12k | 15.49 |
| 2019-06-30 | $210k | 12k | 17.21 |
| 2019-03-31 | $172k | 11k | 16.10 |
| 2018-12-31 | $156k | 11k | 14.60 |
| 2018-09-30 | $194k | 11k | 18.16 |
| 2018-06-30 | $180k | 11k | 16.85 |
| 2018-03-31 | $199k | 10k | 19.57 |
| 2017-12-31 | $206k | 10k | 20.26 |
| 2017-09-30 | $122k | 9.4k | 12.96 |
| 2017-06-30 | $121k | 9.4k | 12.85 |
| 2017-03-31 | $122k | 9.4k | 12.96 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors